NA

Nabirasool Ameensab Mamadapur

Director Additional Director DIN 06452297
DIN 06452297 First appointment Dec 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Nabirasool Ameensab Mamadapur

Data last updated:

Nabirasool Ameensab Mamadapur was an Additional Director at Evantas Biotec Private Limited (2012–2019). The company operates in Pharma.

DIN 06452297
Primary Designation Additional Director
Industry Pharma
First Appointment 15 Dec 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evantas Biotec Private Limited U24132KA2012PTC064392
Additional Director15 Dec 20122012₹53.7 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evantas Biotec Private Limited
Premium access

Shareholding and investment profile for Nabirasool Ameensab Mamadapur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nabirasool Ameensab Mamadapur

Nabirasool Ameensab Mamadapur was first appointed on 15 Dec 2012 as Additional Director at Evantas Biotec Private Limited.

Nabirasool Ameensab Mamadapur held 1 earlier board appointment: Evantas Biotec Private Limited (Additional Director, 15 Dec 2012 to 16 May 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available